Some hard cold reality is setting in today. All o
Post# of 148158
Discussions with Big Pharma...give me a break. I heard this every call since I bought in Q1 of 2018, and it's a joke. I can't say it's an outright lie, but there isn't anyone out there ready to cut a deal with Cytodyn for either a buyout or licensing opportunities. 0-25 in three years, and 25 may be low for the number of mentions.
NASDAQ DOA.
BLA by "EOY". I heard that about the same time last year.
Longhaulers is a waste of time.
P3 CD10 will be in line behind other products before completed.
Full enrollment on CD12 is 4-6 months from having data we could use.
So where are we on CD12? The high number of deaths gives us a chance to show statistical significance beyond a shadow of a doubt and mandate that they halt the trial and give us EUA...on the other hand, the high number of deaths could mean we aren't working as well as we hoped.